Abdenour Nabid
About
Abdenour Nabid is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery.
According to data from OpenAlex, Abdenour Nabid has authored 99 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Pulmonary and Respiratory Medicine, 32 papers in Oncology and 26 papers in Surgery. Recurrent topics in Abdenour Nabid's work include Prostate Cancer Treatment and Research (37 papers), Prostate Cancer Diagnosis and Treatment (28 papers) and Management of metastatic bone disease (17 papers). Abdenour Nabid is often cited by papers focused on Prostate Cancer Treatment and Research (37 papers), Prostate Cancer Diagnosis and Treatment (28 papers) and Management of metastatic bone disease (17 papers). Abdenour Nabid collaborates with scholars based in Canada, United States and Australia. Abdenour Nabid's co-authors include A. Fortin, Isabelle Bairati, Bernard Têtu, François Brochet, François Meyer, Michel Gélinas, Sylvie Vass, François Harel, Michael Brundage and Rebecca Wong and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.
In The Last Decade
Abdenour Nabid
96 papers receiving 2.5k citations
Peers
Abdenour Nabid
Liang Zeng Canada
David P. Kelsen United States
Jun Liang China
Allan J. Schutt United States
Yu–Chung Wu Taiwan
Joanne Davis United States
John C. Michalak United States
Thomas A. Colacchio United States
R. Cellerino Italy
Linda L. Garland United States
Citations per year, relative to Abdenour Nabid Abdenour Nabid (= 1×)
peers
Liang Zeng
Countries citing papers authored by Abdenour Nabid
Since
Specialization
Citations
This map shows the geographic impact of Abdenour Nabid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdenour Nabid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdenour Nabid more than expected).
Fields of papers citing papers by Abdenour Nabid
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Abdenour Nabid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdenour Nabid. The network helps show where Abdenour Nabid may publish in the future.
Co-authorship network of co-authors of Abdenour Nabid
This figure shows the co-authorship network connecting the top 25 collaborators of Abdenour Nabid. A scholar is included among the top collaborators of Abdenour Nabid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abdenour Nabid. Abdenour Nabid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Roy, Soumyajit, Tahmineh Romero, David Joseph, et al.. (2024). Natural History after Likely Cure vs. Recurrence vs. after ProsTate RadiOtheRapy (RAPTOR): A Pooled Analysis of More than 13000 Patients from 21 Randomized Controlled Trials. International Journal of Radiation Oncology*Biology*Physics. 120(2). S75–S76.
2.
Niazi, Tamim, Abdenour Nabid, Talía Malagón, et al.. (2024). Hypofractionated Dose Escalation Radiotherapy for High-Risk Prostate Cancer: the survival analysis of the Prostate Cancer Study-5 (PCS-5), a GROUQ-led phase III trial. European Urology. 87(3). 314–323.
3.
Nabid, Abdenour, Nathalie Carrier, André‐Guy Martin, et al.. (2024). Quality of life and testosterone recovery after androgen deprivation therapy in high-risk prostate cancer patients: long-term data from a phase III trial. Quality of Life Research. 34(3). 725–737.
4.
Niazi, Tamim, Abdenour Nabid, Talía Malagón, et al.. (2023). Hypofractionated, Dose Escalation Radiation Therapy for High-Risk Prostate Cancer: The Safety Analysis of the Prostate Cancer Study-5, a Groupe de Radio-Oncologie Génito-Urinaire de Quebec Led Phase 3 Trial. International Journal of Radiation Oncology*Biology*Physics. 118(1). 52–62.
5.
Nabid, Abdenour, Nathalie Carrier, André‐Guy Martin, et al.. (2023). Quality of life comparison based on testosterone recovery after androgen deprivation therapy in patients cured from high-risk prostate cancer: Long term data from a phase III trial.. JCO Oncology Practice. 19(11_suppl). 333–333.
6.
Ong, Wee Loon, Holly Wilhalme, Jeremy Millar, et al.. (2023). 34 Testosterone Recovery Following Androgen Suppression and Prostate Radiotherapy (Transport) - Updated Analyses from the MARCAP Consortium. Radiotherapy and Oncology. 186. S18–S18.
7.
Ong, Wee Loon, Nathalie Carrier, Tahmineh Romero, et al.. (2023). Prostate-Specific Antigen Response to Androgen Deprivation Therapy in the Neoadjuvant Setting for High-Risk Prostate Adenocarcinoma (PIRANHA): Pooled Analysis of Two Randomized Clinical Trials. International Journal of Radiation Oncology*Biology*Physics. 119(3). 826–831.
8.
Roy, Soumyajit, Tahmineh Romero, Allison Steigler, et al.. (2023). Biochemical recurrence (BCR) surrogacy for clinical outcomes after radiotherapy for adenocarcinoma of the prostate (BCRSCRAP): A meta-analysis from MARCAP Consortium.. Journal of Clinical Oncology. 41(6_suppl). 391–391.
9.
Tsui, James Man Git, Michael Jonathan Kucharczyk, Abdenour Nabid, et al.. (2021). The Clinical Significance of Bone Mineral Density Changes Following Long-Term Androgen Deprivation Therapy in Localized Prostate Cancer Patients. The Journal of Urology. 205(6). 1648–1654.
10.
Chow, Selina, Keyue Ding, Bo Wan, et al.. (2017). Gender differences in pain and patient reported outcomes: a secondary analysis of the NCIC CTG SC. 23 randomized trial. Annals of Palliative Medicine. 6(S2). S185–S194.
11.
Raman, Srinivas, Keyue Ding, Edward Chow, et al.. (2016). A prospective study validating the EORTC QLQ-BM22 bone metastases module in patients with painful bone metastases undergoing palliative radiotherapy. Radiotherapy and Oncology. 119(2). 208–212.
12.
Mak, Raymond H., Daniel Hunt, Jason A. Efstathiou, et al.. (2016). Acute and late urinary toxicity following radiation in men with an intact prostate gland or after a radical prostatectomy: A secondary analysis of RTOG 94-08 and 96-01. Urologic Oncology Seminars and Original Investigations. 34(10). 430.e1–430.e7.
13.
Chow, Edward, Carlo DeAngelis, Bingshu E. Chen, et al.. (2015). Effect of re-irradiation for painful bone metastases on urinary markers of osteoclast activity (NCIC CTG SC.20U). Radiotherapy and Oncology. 115(1). 141–148.
14.
Chow, Edward, Yvette M. van der Linden, Daniel Roos, et al.. (2013). Single versus multiple fractions of repeat radiation for painful bone metastases: a randomised, controlled, non-inferiority trial. The Lancet Oncology. 15(2). 164–171.
15.
Kachnic, Lisa A., Stephanie L. Pugh, Patricia Tai, et al.. (2013). RTOG 0518: randomized phase III trial to evaluate zoledronic acid for prevention of osteoporosis and associated fractures in prostate cancer patients. Prostate Cancer and Prostatic Diseases. 16(4). 382–386.
16.
Nourissat, Alice, Isabelle Bairati, A. Fortin, et al.. (2011). Factors associated with weight loss during radiotherapy in patients with stage I or II head and neck cancer. Supportive Care in Cancer. 20(3). 591–599.
17.
Bairati, Isabelle, François Meyer, Michel Gélinas, et al.. (2006). Antioxidant vitamins supplementation and mortality: A randomized trial in head and neck cancer patients. International Journal of Cancer. 119(9). 2221–2224.
18.
Suh, John H., Baldassarre Stea, Abdenour Nabid, et al.. (2005). Phase III Study of Efaproxiral As an Adjunct to Whole-Brain Radiation Therapy for Brain Metastases. Journal of Clinical Oncology. 24(1). 106–114.
19.
Roth, Stephan, Jean Claude Horiot, G. Calais, Abdenour Nabid, & M.C. Böne-Lépinoy. (1989). Prognostic factors in limited rectal cancer treated with intracavitary irradiation. International Journal of Radiation Oncology*Biology*Physics. 16(6). 1445–1451.
20.
Roth, Stephan, et al.. (1988). Results of Endocavitary Irradiation of Early Rectal Tumors. Acta Oncologica. 27(6). 825–827.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Liang Zeng Breakdown of academic impact, for papers by David P. Kelsen Breakdown of academic impact, for papers by Jun Liang Breakdown of academic impact, for papers by Allan J. Schutt Breakdown of academic impact, for papers by Yu–Chung Wu Breakdown of academic impact, for papers by Joanne Davis Breakdown of academic impact, for papers by John C. Michalak Breakdown of academic impact, for papers by Thomas A. Colacchio Breakdown of academic impact, for papers by R. Cellerino Breakdown of academic impact, for papers by Linda L. Garland